Research relationships between U. scientists, industry lead to promising results
In February 2004, the anti-cancer drug Alimta, developed by late chemistry Professor Emeritus Edward Taylor in collaboration with pharmaceutical giant Eli Lilly, was approved by the FDA for the treatment of several forms of deadly lung cancer. “Collaboration between academia and industry is really a win-win situation for both sides,” Dean for Research Pablo Debenedetti said, recounting the story of Alimta.